PolyPeptide Group AG (PPGN) CHF0.01
Sell:22.50 CHFBuy:24.90 CHF
0.10 CHF
(0.44%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:22.50 CHF
Buy:24.90 CHF
Change:0.10 CHF
(0.44%)
0.10 CHF
(0.44%)Prices delayed by at least 15 minutes
Sell:22.50 CHF
Buy:24.90 CHF
Change:0.10 CHF
(0.44%)
0.10 CHF
(0.44%)Prices delayed by at least 15 minutes
Company Information
About this company
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Key people
Juan-Jose Gonzalez
Chief Executive Officer
Marc Augustin
Chief Financial Officer
Christina Del Vecchio
General Counsel, Corporate Secretary
Neil James Thompson
Director Global Sales and Marketing
Jens Fricke
Director Global Operations
Peter Wilden
Non-Executive Chairman of the Board
Patrick Aebischer
Non-Executive Vice Chairman of the Board, Lead Independent Director
Jane Salik
Non-Executive Director
Erik Schropp
Non-Executive Director
Dorothee Anna Deuring
Non-Executive Independent Director
Click to see more
Key facts
- EPIC-
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINCH1110760852
- Market capCHF 756.99m
- Employees1,277
- Shares in issue33.13m
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.